The majority of cardiovascular laboratories concerned with diagnostic investigations routinely employ a variety of analgesic and sedative drugs during intravascular procedures. There is little doubt that many of these drugs have significant PHARMACOLOGY Dehydrobenzperidol. This drug, marketed under the trade name of droperidol, is one of the butyrophenone series of neuroleptic drugs with the configuration shown below. hwmodynamic effects. At present the most commonly used sedatives are probably the barbiturate or opiate derivatives, but both groups of drugs have been shown to produce notable circulatory changes. The search, therefore, continues for drugs of equal sedative power but with less direct effects on the circulation. Dehydrobenzperidol and phenoperidine in combination have achieved some popularity for their analgesic and sedative effects during neurosurgical stereotaxic operations (Brown, 1964) . A distinctive feature of these drugs has been the complete freedom of the patient from any distress during this exacting procedure, while full powers of co-operation are retained. Moreover, this drug combination caused no appreciable change in heart rate or blood pressure. Such drug-induced neuroleptanalgesia might therefore be superior to the methods of sedation generally used for cardiovascular procedures. The present report concerns a trial of these drugs alone and in combination in patients with rheumatic heart disease undergoing diagnostic circulatory investigation; it also attempts more detailed analysis of their hemodynamic effects. Received October 21, 1965. 654 In the conscious experimental animal, dehydrobenzperidol (DHBP) produces a marked cataleptic state with powerful inhibition of conditioned reflexes. High doses of the drug are associated with a fall in the systemic vascular resistance and blood pressure, and these circulatory effects are significantly potentiated by anesthesia or barbiturates. However, in the doses usually employed these circulatory changes are minimal. The drug also appears to block the circulatory effects of exogenous catecholamines, both in the rat and the cat. In the anaesthetized dog, the drug seems to produce a conspicuous hypersensitivity to carbon dioxide with an increase in the minute ventilation. These effects of the drug in the experimental animal have been presented in more detail by Janssen et al. (1963) .
In (Brown, 1963) .
Phenoperidine. This drug is a derivative of pethidine, the N-methyl group being replaced by a phenyl-propinyl chain. It has the following chemical configuration:
The effect of the drug in animals appears to be very similar to that of morphine. The first effect of the drug is to produce a reduced state of reactivity to noxious stimuli; this is followed by increasing depression of brain-stem function as the dose is increased up to a state of respiratory failure. These effects are rapidly and apparently completely reversed by nalorphine. The effects of the drug on the circulation in animals are not known.
In man, phenoperidine has powerful analgesic and sedative properties. Although respiratory depression occurs, particularly if a dose of 2 mg. is exceeded, few effects on the circulation have been described (Rollason and Sutherland, 1963 CLINICAL TRIAL DHBP, alone or in combination with phenoperidine, was administered to 65 patients undergoing diagnostic cardiac investigation to assess their suitability for surgical treatment. The age range of the patients was 4-61 years, and 16 of the 65 were under 13 years of age. Thirty-nine patients suffered from congenital heart disease and 20 from rheumatic heart disease. In 4 no abnormality was discovered, and the remaining 2 were found to be suffering from cardiomyopathies of unknown cause. Catheterization of the right heart was performed in 48 patients, in 9 of whom cine-angiography was also performed. In a further 17 patients, left ventricular catheterization and angiography were carried out either by the Brockenburgh or by retrograde techniques.
Dosage. Adult subjects received 5 mg. of DHBP intravenously one hour before the procedure, and in 11 patients this gave satisfactory sedation on its own. In the remaining 54 patients, however, phenoperidine was further required to give an adequate level of sedation; this was given immediately before the intravascular procedure, in a dose of 0-02 mg./kg. body weight, with a subsequent additional dose if the investigation was prolonged.
:2H5
The total dosage of phenoperidine used varied between 002 and 0-04 mg./kg. body weight. In 8 children between the ages of 4 and 6 years DHBP was given by intra-HCL muscular injection in a dose of 10 mg. two hours before the procedure. The other 8 children received 4 mg. intravenously one hour before. Phenoperidine was again given to a total dose of 0'04 mg./kg. body weight.
Efficacy. With these drugs, alone or in combination, satisfactory sedation was achieved in 63 of the 65 patients. They remained completely immobile for periods of up to two hours but responded to simple instructions and were fully capable of performing supine leg exercise.
Side-effects. Vomiting occurred in 3 patients and a further 4 experienced nausea while recovering in the ward after the procedure. The respiratory rate fell in all cases receiving phenoperidine, but this never caused anxiety and none of the patients required nalorphine.
In only two instances did the premedication prevent the planned investigation. A man aged 39 years with aortic stenosis complained of general malaise, a feeling of breathlessness, and of the legs "shrinking up into his body", within 10 minutes of the intravenous injection of 5 mg. of DHBP. Clinical examination revealed no abnormality, but because of the patient's mental distress the CIRCULATORY STUDIES The pharmacological activity of these drugs on the circulation in man was studied by observing their effects on the pulmonary and systemic circulations in rheumatic heart disease.
METHODS
Clinical details. Studies were made on 6 patients with mitral valve disease undergoing diagnostic circulatory investigations. The personal and clinical details of these patients are given in Table I. Plan of investigation. Previous studies have shown that a more stable basal circulatory state may be induced in patients under investigation by a short period of nonfatiguing leg exercise (Taylor et al., 1962) . All subjects in the present study were therefore required to carry out light supine leg exercise for five minutes, during which measurements were made to assess the circulatory response to exercise. Thereafter, they were allowed a 15-minute recovery period to permit the return of the circulation to a more basal level. At the end of this period a control study was carried out in which the systemic arterial, pulmonary arterial, and pulmonary wedge pressures were measured for 10 minutes, and during this time the cardiac output was measured at 2-minute intervals. At the end of the control period, 4 patients (C. G., I. W., E. B., and R. B.) were given an intravenous infusion of dehydrobenzperidol (DHBP) in saline in a concentration of 1 mg./ml. at a rate of 1 ml./ min. until a total dose of 10 mg. had been administered. Intravascular pressures were recorded continuously for the next hour; the cardiac output was measured at 2-minute intervals for 20 minutes and then at 5-minute intervals to the end of the period of study. (Taylor, 1966; Taylor et al., 1967a) . During these studies the cardiac output was monitored continuously by means ofa Gilford computer, the use and standardization of which will be reported later (Taylor et al., 1967b) . The heart rate was determined from a continuously recorded electrocardiogram.
Measurements and calculations. Cardiac output and cardiopulmonary blood volume were calculated according to the conventional Hamilton formula. The dye curve downslope was extrapolated through two whole logarithmic cycles, trapezoidal approximations being made at half second intervals. The minimum number of points on the direct plot accepted for trial fitting of the extrapolation was six and in all curves a straight line segment was readily discemible. The calculation of the mean systemic and pulmonary vascular resistances was modified to incorporate a correction for body surface area, the arguments for which have been previously presented (Taylor et al., 1962) .
RESULTS
The primary measurements and derived variables are illustrated in Fig. 1-4 . Reference to these figures demonstrates that the circulatory changes produced by these drugs alone or in combination were constantly changing, though distinct trends in the majority of these parameters are clearly discernible.
Circulatory effects of dehydrobenzperidol. The systemic circulatory changes due to the infusion of the drug were consistent in three of the four patients. In three patients (C. G., I. W., and E. B.) the start of the infusion was promptly followed by a fall in systemic vascular resistance which continued throughout the remainder of the 10 minutes the drug was being administered. With completion of the infusion the systemic resistance gradually returned to pre-infusion values with a lag varying between 10 and 30 minutes. In none of these patients was a compensatory increase in heart rate or cardiac output observed, so that the fall in systemic vascular resistance was clearly reflected in the changes in systemic arterial pressure (Fig. 1) . In the fourth patient (R. B.), a fall in systemic vascular resistance was not noted until 10 minutes after completion of the infusion of the drug, though there was a small fall in cardiac output during and immediately after the infusion. Administration of the drug was associated with no consistent changes in stroke volume in any of the patients.
The changes in the pulmonary circulation due to the drug are illustrated in Fig. 2 . The infusion was associated with a small fall in both the pulmonary arterial and pulmonary wedge pressures in all four patients. In two (I. W. and E. B.) completion of the infusion was not accompanied by any further fall, the pulmonary pressures remaining at these lower levels for the remainder of the period of observation. In two other patients (C. G. and R. B.) both pressures continued to fall gradually for up to 30 minutes after stopping the infusion. In all except one patient (I. W.) the reduction in pulmonary vascular pressures was proportionately greater in the pulmonary arterial than in the pulmonary wedge pressures. In these three patients the calculated mean pulmonary vascular resistance was reduced during and after the infusion. In the one exception (I. W.) the fall in the pulmonary arterial and wedge pressures was of a similar order, and this, allied to the small reduction in the cardiac output, resulted in a small increase in the calculated pulmonary vascular resistance. The maximum reductions in the pulmonary vascular pressures were observed in those patients (C. G. and R. B.) with the highest initial pressures. The drug had no consistent effect on the cardiopulmonary blood volume within the one-hour period of the observations. Circulatory effects of phenoperidine. The changes in the systemic circulation produced by the injection of 1-5 mg. phenoperidine were similar in direction but much less in degree than those observed following the infusion of dehydrobenzperidol. Injection C.G. of the drug was followed by a gradual reduction in the systemic vascular resistance, which, in the absence of appreciable changes in cardiac output, resulted in small reductions in the systemic arterial blood pressure in both patients (Fig. 3) . There was no consistent change in heart rate or stroke volume in either patient following the injection. In the pulmonary circulation, the intravenous injection of 1-5 mg. phenoperidine produced different responses in the two patients studied (Fig. 4) . In one (A. T.) the injection was followed by a consistent and prolonged fall in the pulmonary wedge pressure without change in the pulmonary arterial pressure. Effect of the drugs on total body oxygen uptake.
The infusion of dehydrobenzperidol resulted in a reduction in the total body oxygen uptake which continued throughout the infusion in all four patients (Fig. 5) in oxygen uptake was maintained for the remainder infusion of dehydrobenzperidol resulted in no ofthe one-hour period ofobservation. The changes significant change in systemic arterial blood oxygen in total body oxygen uptake following the injection or carbon dioxide tensions and no change in arterial of phenoperidine were in a similar direction but blood pH or percentage oxygen saturation in any of much less in degree (Fig. 6) . the four patients (Fig. 7) . The injection of phenoperidine resulted in Effect of drugs on systemic arterial blood gas significant respiratory depression in both of the tensions, pH, and percentage oxygen saturation. The patients to whom it was given (Table II) Both drugs produced conspicuous changes in both the systemic and pulmonary circulations, but these were most obvious after dehydrobenzperidol. The immediate fall in blood pressure due to the reduction in systemic resistance that promptly followed the infusion ofthe drug was unaccompanied by any compensatory increase in heart rate or cardiac output. In fact, in three patients, both the heart rate and cardiac output declined somewhat after the drug. These findings taken together have three implications. First, the fact that the heart rate and cardiac output were not raised during the control period and did not promptly fall after the drug would imply that these patients were in a relatively basal state at the time of its administration. Secondly, the abrupt reduction in systemic and pulmonary vascular resistances that followed its infusion implies an immediate and direct effect on the resistance vessels in both circuits. Thirdly, the absence of any compensatory reflex elevation of the heart rate and cardiac output to counteract the fall in systemic blood pressure suggests a druginduced insensitivity of the afferent baroreceptor mechanisms or blockade of the normal catecholamine-sympathetic efferent reflex arc. As the drug appears to antagonize both adrenaline and noradrenalin in the experimental animal, the latter mechanism is the more likely. (Hoff and Green, 1936 Satisfactory sedation was obtained with dehydrobenzperidol alone in 11 of the 65 patients. In the remainder phenoperidine was necessary in addition to obtain adequate sedation. Two of the patients developed abnormal psychomotor behaviour after dehydrobenzperidol. Significant respiratory depression was noted after phenoperidine but not after dehydrobenzperidol.
Dehydrobenzperidol resulted in widespread vasodilatation of the systemic and pulmonary circulatory beds, probably due to a direct effect on the resistance vessels. The resulting fall in systemic blood pressure did not result in a reflex increase in heart rate and cardiac output possibly owing to catecholamine antagonism. The 
